Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
114.04Price to Sales
VS
Market
Sector
Industry
History
$ 2.61Close
$ 1.18 - $ 11.68 52-Week Range
Ticker Information
Ticker
BTAICompany Name
BIOXCEL THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQBIOXCEL THERAPEUTICS INC - Price to Sales Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
BTAI - P/S Historical data
| Date | Market Capitalization | Price to Sales | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 98.99M | 114.04 | $ 868K |
| 3/31/2025 | $ 8.96M | 4.84 | $ 1.85M |
| 12/31/2024 | $ 11.63M | 5.13 | $ 2.27M |
| 9/30/2024 | $ 22.25M | 9.77 | $ 2.28M |
| 6/30/2024 | $ 39.11M | 16.28 | $ 2.4M |
| 3/31/2024 | $ 86.51M | 49.26 | $ 1.76M |
| 12/31/2023 | $ 85.92M | 62.26 | $ 1.38M |
| 9/30/2023 | $ 123.53M | 99.46 | $ 1.24M |
| 6/30/2023 | $ 126.73M | 122.09 | $ 1.04M |
| 3/31/2023 | $ 794.89M | 1.37K | $ 581K |
Key Performance Insights, Last 5 Years
- BIOXCEL THERAPEUTICS INC's latest trailing twelve months (TTM) P/S stands at 0.
- Over the past 5 years, BIOXCEL THERAPEUTICS INC's average P/S has been 556.42.
- The median P/S for BIOXCEL THERAPEUTICS INC during this period was 80.86
- BIOXCEL THERAPEUTICS INC reached its highest P/S over the past 5 years at 3.32K.
- The lowest P/S recorded by BIOXCEL THERAPEUTICS INC in the same timeframe 4.84
BIOXCEL THERAPEUTICS INC's P/S vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/S Benchmarks
Similar metrics to Revenues:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Book - [Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Price to Sales
[Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].Market Cap / Revenues
(=) P/S P/S for BIOXCEL THERAPEUTICS INC is calculated as follows: Market Cap [ $ 1.34B ] / Revenues [ $ 0 ]
(=) P/S [ 0 ] BTAI - Price to Sales, Last 5 years
4.84
Minimum
Mar 31, 2025
3.32K
Maximum
Sep 30, 2022
556.42
Average
80.86
Median
P/S Benchmark AnalysisMarket
The chart above depicts the distribution of P/S for companies in the Total Stock Market. The average P/S of the companies is 2.62 with a standard deviation of 2.38.
The following table provides additional summary stats:
P/S in the Market:
| filtered constituents | 3.41K |
|---|---|
| min | 0 |
| max | 11.15 |
| average | 2.62 |
| median | 1.97 |
| std | 2.38 |